Dornase

Part of speech: noun

Definitions

1. An enzyme used medically to break down DNA in mucus to reduce its viscosity and improve clearance from airways; a type of DNase enzyme employed in cystic fibrosis treatment to aid respiratory function; a protein preparation that cleaves extracellular DNA to help decrease mucus thickness in certain pulmonary diseases
2. A pharmaceutical enzyme designed to fragment extracellular DNA in thick secretions, facilitating mucus clearance particularly in respiratory conditions; a DNase type that targets DNA to reduce mucus viscosity in airway disorders; a therapeutic agent used to enzymatically digest DNA in pulmonary mucus for easier expectoration
3. An enzyme drug that enzymatically cuts DNA strands in viscous mucus to thin secretions and support lung function; a DNA-cleaving enzyme applied in medical treatments for mucus buildup in lungs; a recombinant protein used to degrade DNA and improve mucus removal in chronic respiratory illness management

Etymology: The term originates from the name of a pharmaceutical enzyme preparation, specifically derived from the enzyme deoxyribonuclease (DNase). Dornase is a recombinant form of human DNase I, an enzyme that cleaves DNA molecules. It was developed for medical use, particularly in treating cystic fibrosis, where it helps break down DNA in the mucus of patients’ lungs, thereby reducing its viscosity and improving respiratory function. This name is a blend of "DNA" and the suffix "-ase," which is commonly used in biochemistry to indicate enzymes. The suffix "-ase" was first used in the late 19th century and has since become a standard ending to denote enzymes, signaling the catalytic nature of the substance. The "dorn-" part is a contracted form relating to "deoxyribonucleic," referencing the enzyme’s substrate. The coined term appeared in the late 20th century alongside advances in biotechnology, as recombinant DNA technology allowed for the production of human enzymes by genetically engineered bacteria or other cells. Dornase alfa, the commercial drug form, was approved in the 1990s, marking the first therapeutic use of DNase outside of laboratory research. In essence, the word emerged from scientific nomenclature practices, where functional description and enzyme classification combine into a concise label. Its lineage traces through modern molecular biology rather than ancient linguistic roots, reflecting its 20th-century medical innovation rather than a traditional lexical heritage.

Synonyms: dornase alfa, pulmozyme